Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 2/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15841459 | 0.81 | SLC1A3 (0.48) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL15841657 | 0.81 | SLC1A3 (0.48) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL379304 | 0.81 | SLC1A3 (0.48) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL3409711 | 0.79 | CA1 (0.41) | SLC1A3SLC1A2SLC1A1MMP1MMP2 | |
| SCHEMBL2985403 | 0.79 | MMP1 (0.32) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL26940431 | 0.76 | SLC1A3 (0.48) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL1196043 | 0.76 | SLC1A3 (0.65) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL1197330 | 0.76 | SLC1A3 (0.65) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL10591110 | 0.76 | SLC1A3 (0.65) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL606620 | 0.76 | SLC1A3 (0.65) | SLC1A3SLC1A2SLC1A1TP53MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756239-A1 | SUPER-ABSORBENT PRINTABLE COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-28 | — | — | EP | claimed |
| WO-2005121260-A1 | SUPER-ABSORBENT PRINTABLE COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-22 | — | — | WO | claimed |
| US-10551566-B2 | Method of preparing an optical connector and optical devices comprising the optical connector prepared thereby | DOW SILICONES CORPORATION (US) | 2020-02-04 | — | — | US | disclosed |
| US-10435585-B2 | Curable composition, method of preparing cured article, and cured article formed thereby | DOW CORNING CORPORATION (US) | 2019-10-08 | — | — | US | disclosed |
| EP-2996867-B1 | METHOD OF PREPARING AN ARTICLE AND ARTICLE PREPARED THEREBY | DOW SILICONES CORP (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-3164449-A1 | METHODS FOR PREPARING ARTICLES AND ASSOCIATED ARTICLES PREPARED THEREBY | Dow Corning Corporation (US) | 2017-05-10 | — | — | EP | disclosed |
| US-20170107331-A1 | Methods For Preparing Articles And Associated Articles Prepared Thereby | DOW CORNING CORPORATION (US) | 2017-04-20 | — | — | US | disclosed |
| US-20160349455-A1 | METHOD OF PREPARING AN OPTICAL CONNECTOR AND OPTICAL DEVICES COMPRISING THE OPTICAL CONNECTOR PREPARED THEREBY | DOW SILICONES CORPORATION | 2016-12-01 | — | — | US | disclosed |
| US-20160102226-A1 | Curable Composition, Method Of Preparing Cured Article, And Cured Article Formed Thereby | DOW SILICONES CORPORATION | 2016-04-14 | — | — | US | disclosed |
| EP-2996867-A1 | METHOD OF PREPARING AN ARTICLE AND ARTICLE PREPARED THEREBY | Dow Corning Corporation (US) | 2016-03-23 | — | — | EP | disclosed |
| EP-2997101-A1 | CURABLE COMPOSITION, METHOD OF PREPARING CURED ARTICLE, AND CURED ARTICLE FORMED THEREBY | Dow Corning Corporation (US) | 2016-03-23 | — | — | EP | disclosed |
| EP-1945397-A2 | BRAZING MATERIAL WITH CONTINUOUS LENGTH LAYER OF ELASTOMER CONTAINING A FLUX | Wolverine Tube, Inc. (US) | 2008-07-23 | — | — | EP | disclosed |
| US-20080058441-A1 | Active Energy Ray-Curable, Organopolysiloxane Resin Composition, Light-Transmitting Component, And Method For Manufacturing The Light-Transmitting Component | DOW TORAY CO., LTD. (JP) | 2008-03-06 | — | — | US | disclosed |
| EP-1877863-A2 | ADJUSTABLE SOLUBILITY IN SACRIFICIAL LAYERS FOR MICROFABRICATION | The President and Fellows of Harvard College (US) | 2008-01-16 | — | — | EP | disclosed |
| WO-2007058969-A2 | BRAZING MATERIAL WITH CONTINUOUS LENGTH LAYER OF ELASTOMER CONTAINING A FLUX | WOLVERINE TUBE, INC. (US) | 2007-05-24 | — | — | WO | disclosed |
| EP-1756239-A1 | SUPER-ABSORBENT PRINTABLE COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2007-02-28 | — | — | EP | disclosed |
| WO-2006113492-A2 | ADJUSTABLE SOLUBILITY IN SACRIFICIAL LAYERS FOR MICROFABRICATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2006-10-26 | — | — | WO | disclosed |
| WO-2005121260-A1 | SUPER-ABSORBENT PRINTABLE COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-22 | — | — | WO | disclosed |
| EP-1244479-A1 | PROTECTIVE COATINGS FOR MEDICAL DEVICES | Boston Scientific Limited (BB) | 2002-10-02 | — | — | EP | disclosed |
| WO-2001049337-A1 | PROTECTIVE COATINGS FOR MEDICAL DEVICES | SCIMED LIFE SYSTEMS, INC. (US) | 2001-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10435585-B2 | Curable composition, method of preparing cured article, and cured article formed thereby | SETDB1, SETD2, SETD1A | SLC1A3 1925/4885SLC1A2 2279/4885SLC1A1 2205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.